Evidence map›Paper›PMID 37589658›Full record

ArticleACS nano2023

Human Immunodeficiency Virus 1 Preferentially Fuses with pH-Neutral Endocytic Vesicles in Cell Lines and Human Primary CD4+ T-Cells.

Manish Sharma, Mariana Marin, Hui Wu, David Prikryl, Gregory B Melikyan

Open access · hybridAbstract read
In one paragraph

Article in ACS nano, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Macropinosomes are a site of HIV-1 entry into primary CD4Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Review
  9. Article
  10. Myosin IXB protects immune cells from virus infection.The Journal of general virology · 2025
    Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Manish SharmaDepartment of Pediatrics, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia 30322, United States.
Mariana MarinDepartment of Pediatrics, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia 30322, United States.
Hui WuDepartment of Pediatrics, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia 30322, United States.
David PrikrylDepartment of Pediatrics, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia 30322, United States.
Gregory B MelikyanDepartment of Pediatrics, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia 30322, United States.ORCID 0000-0001-5385-3013
Emory University · US

Funding

Biophysics of Protein-Mediated Membrane FusionR37AI150453 · NIAID · EMORY UNIVERSITY · PI Gregory B Melikian · 2020 to 2026
$4.1M
Biophysics of Protein-Mediated Membrane FusionR01AI150453 · NIAID · EMORY UNIVERSITY · PI MELIKIAN, GREGORY B · 2019 to 2019
$466k
NIAID NIH HHS R01 AI150453NIAID NIH HHS R37 AI150453
6 · The paper itself

Abstract

Despite extensive efforts, the principal sites of productive HIV-1 entry in different target cells─plasma membrane (PM) vs endosomes─remain controversial. To delineate the site(s) of HIV-1 fusion, we implemented a triple labeling approach that involves tagging pseudoviruses with the fluid-phase viral content marker, iCherry, the viral membrane marker, DiD, and the extraviral pH sensor, ecliptic pHluorin. The viral content marker iCherry is released into the cytoplasm upon virus-cell fusion irrespective of the sites of fusion. In contrast, the extent of dilution of the membrane marker upon fusion with the PM (loss of signal) vs the endosomal membrane (no change in punctate DiD appearance) discriminates between the principal sites of viral fusion. Additionally, ecliptic pHluorin incorporated into the viral membrane reports whether virus fusion occurs in acidic endosomes. Real-time single virus imaging in living HeLa-derived cells, a CD4+ T-cell line, and activated primary human CD4+ T-cells revealed a strong (80-90%) HIV-1 preference for fusion with endosomes. Intriguingly, we observed HIV-1 fusion only with pH-neutral intracellular vesicles and never with acidified endosomes. These endocytic fusion events are likely culminating in productive infection since endocytic inhibitors, such as EIPA, Pitstop2, and Dynasore, as well as a dominant-negative dynamin-2 mutant, inhibited HIV-1 infection in HeLa-derived and primary CD4+ T-cells. Furthermore, the inhibition of endocytosis in HeLa-derived cells promoted hemifusion at the PM but abrogated complete fusion. Collectively, these data reveal that the primary HIV-1 entry pathway in diverse cell types is through fusion with pH-neutral intracellular vesicles.

Indexed as

HIV-1CD4-Positive T-LymphocytesHeLa CellsHumansHydrogen-Ion ConcentrationTransport Vesiclesendocytosismembrane fusionpH-sensingsingle virus trackingvirus labeling

Identifiers

PMID37589658
PMCPMC10510587
OpenAlexW4385898510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.